Navigation Links
Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
Date:10/10/2007

Phase 1b/2 Study to Explore the Efficacy of Novel Proteasome Inhibitor in

Patients with Relapsed Solid Tumors

SOUTH SAN FRANCISCO, Calif., and SAN ANTONIO, Oct. 10 /PRNewswire/ -- Proteolix, Inc. and South Texas Accelerated Research Therapeutics (START) today announced the enrollment of the first patient in a Phase 1 clinical trial to study Proteolix's investigational drug, carfilzomib (PR-171). START is participating in the study under the leadership of Kyriakos Papadopoulos, M.D., MSc, FCP(SA).

This trial is evaluating single agent carfilzomib, a novel proteasome inhibitor, in patients with recurrent or advanced solid tumors. The Phase 1b portion of the study is a dose-escalation study designed to determine the maximum tolerated dose of carfilzomib administered intravenously in patients with solid tumors. After determining the maximum tolerated dose, additional patients will be enrolled in Phase 2 and stratified according to disease type, including non-small cell lung cancer, small cell lung cancer, ovarian cancer and renal cancer.

"We are very excited about beginning this study in San Antonio. This next generation proteasome inhibitor has shown promising activity in myeloma and will offer a new option to our patients with advanced cancer," said Dr. Papadopoulos.

About Carfilzomib

Carfilzomib is a structurally- and mechanistically-novel proteasome inhibitor that exhibits a high level of selectivity for a single active site in the proteasome with minimal cross reactivity to other protease classes. Carfilzomib has been shown in both preclinical and clinical studies to be well tolerated on intensive daily dosing schedules; in preclinical models, this intensive dosing results in greatly improved efficacy against solid tumors. Phase 1 clinical studies have shown that patients with hematologic malignancies who have relapsed or progressed following multiple therapies can achieve durable anti-tumor responses with ca
'/>"/>

SOURCE Proteolix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Malvern initiates European user group meetings for chemical imaging
2. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
3. Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimers Disease at International Conference on Prevention of Dementia
4. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
5. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
6. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  UnaliWear announces the ... advanced support for seniors that guards against wandering and ... The new wearable – the Kanega watch ( ... kind to use an easy speech interface rather than ... information without human input. The watch ...
(Date:3/3/2015)...  Michigan brothers Dominique Larkin , 23, and Stan, ... dysplasia, or ARVD, a disease that causes irregular heart rhythms. ... athletes. In 2007, doctors discovered the condition in ... tested Dominique and found his "condition was just as bad ... in The Ann Arbor News , part of the ...
(Date:3/3/2015)... , March 3, 2015 /CNW/ - Sante Medical Hair ... Procedure for hair transplantation. The ARTAS ... safely and effectively extracts hair for transplantation. This ... virtually undetectable results, with no linear scar. ... the ease of hair restoration surgery." says Dr. ...
Breaking Medicine Technology:UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3No linear scar. Permanent results. 2
... 10, 2011 New York City ... the Supply & Demand Chain Executive 100 for a joint ... asset. This year,s list, "100 Great Supply Chain Projects," highlights ... for an enabler,s client. Three years ago, HHC ...
... Marshall Edwards, Inc.(Nasdaq: MSHL ), an oncology ... targeting cancer metabolism, announced today the closing of the ... its majority shareholder, Novogen Limited, and Novogen Research Pty ... transaction follows approval at a meeting of Novogen shareholders ...
Cached Medicine Technology:Joint HHC/GHX Project Earns Honors in Supply & Demand Chain Executive's 2011 Executive 100 2Joint HHC/GHX Project Earns Honors in Supply & Demand Chain Executive's 2011 Executive 100 3Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen 2Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen 3
(Date:3/3/2015)... (PRWEB) March 03, 2015 On February ... complaint in the United States District Court for the ... Financial Freedom, as well as insurance companies Balboa, QBE, ... 2015 in Case No. 3:14-cv-152.) , The Plaintiff, a ... insurance companies to force her to buy too much ...
(Date:3/3/2015)... New York (PRWEB) March 03, 2015 ... tactics used to market the atypical antipsychotic medication ... U.S. According to court documents, the South Carolina ... finding that Johnson & Johnson’s Janssen Pharmaceuticals unit ... serious risks. However, while the Court’s February 25th ...
(Date:3/3/2015)... CA (PRWEB) March 03, 2015 Loma ... to whole health and well being, it will be ... machines across its campuses. , Over the past year, ... took part in creating dietary criteria, listening to vendors, ... for the entire organization. , Most recently, a ...
(Date:3/3/2015)... Today, Steve Weatherford, current New York Giants punter, ... the donation of their brains to science during a ... In an effort to raise awareness for the impact ... Rice and Weatherford spoke of their experiences on and ... health a priority to avoid the consequences of injuries ...
(Date:3/3/2015)... Portland, Oregon (PRWEB) March 03, 2015 ... compassionate community leaders to help find cures and ensure ... the quality of life for patents and their families. ... a maximum impact in the fight for a world ... to the top fundraisers in the country, to be ...
Breaking Medicine News(10 mins):Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3
... Ill., July 7 Lifeway Foods, Inc. (Nasdaq: LWAY ... other natural and organic dairy products, invites you to come watch ... first pitch before the Chicago Cubs take on the Atlanta Braves ... official "Lifeway Day with the Cubs," the local kefir manufacturer will ...
... foods innovator, announced today that it is expanding its premium, all natural ... active consumers a unique, on-the-go snacking alternative that is both decadent and ... flavors--Chocolaty Cherry, Tropical and Fruit and Nut-- Bear Nake d (TM) ... Na tu ral Grain-ola ...
... , JACKSONVILLE, Fla., July 7 Blue Cross and ... numerous health care providers in Broward, Charlotte, Hernando, Pasco, ... care plan. This affordable option features a community-based network, ... percent on services and premiums, without sacrificing quality coverage. ...
... The 2008 Frost & Sullivan Global Food and ... Ireland-based Marigot Ltd. and U.S.-based GTC Nutrition for ... prebiotic-based mineral absorption-enhancer aims at simultaneously promoting bone, ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , , "The ...
... , ... eminent authority on clinical nutrition and preventive medicine, is now a featured expert on searchbloodsugar.com, ... and solutions. , ... (Vocus) July 6, 2009 -- Susan Lark, MD , an eminent authority on clinical ...
... offers safe, simple, effective alternative to tubal ligation , ... (Hologic or the Company) (Nasdaq: HOLX ), ... medical imaging systems and surgical products dedicated to serving ... Food and Drug Administration (FDA) has approved the Company,s ...
Cached Medicine News:Health News:Giant Bugs Invade Wrigley Field 2Health News:Bear Naked Introduces All Natural Granola Bars 2Health News:Blue Cross and Blue Shield of Florida Expands Low-Cost 'BlueSelect' Health Plan to Five Florida Counties 2Health News:Frost & Sullivan Lauds Marigot Ltd. and GTC Nutrition for Their Innovative CalciLife(TM) 2Health News:Frost & Sullivan Lauds Marigot Ltd. and GTC Nutrition for Their Innovative CalciLife(TM) 3Health News:Frost & Sullivan Lauds Marigot Ltd. and GTC Nutrition for Their Innovative CalciLife(TM) 4Health News:Women's Health Expert Dr. Susan Lark Featured on Searchbloodsugar.com 2Health News:Women's Health Expert Dr. Susan Lark Featured on Searchbloodsugar.com 3Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 2Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 3Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 4Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: